Over a quarter of consultations (26%) involved a patient who was born outside of the United States, 23% involved patients with low CD4 counts (<200 cells/mm3), 11% involved questions about concurrent chronic or infectious disease, and 11% mentioned some type of anti-TB drug-resistance, either suspected or confirmed, as shown in Table 3. The gene discussed is CD4; the disease is infectious disease.